Clinical Trial Update: Pre-Hospital Use of Plasma for Traumatic Hemorrhage [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating pre-hospital plasma for traumatic hemorrhage in patients with hemorrhagic shock was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock

Drugs mentioned

• Fresh Frozen Plasma (fresh frozen plasma)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Shock, Hemorrhagic | Phase 2, Phase 3 | Status: WITHDRAWN